# Study to Evaluate the Efficacy and Safety of PAC-14028 Cream in Rosacea Patients

> **NCT02052999** · PHASE2 · COMPLETED · sponsor: **Amorepacific Corporation** · enrollment: 80 (actual)

## Conditions studied

- Erythematotelangiectatic Rosacea
- Papulopustular Rosacea

## Interventions

- **DRUG:** PAC-14028 cream 1%
- **OTHER:** Vehicle
- **DRUG:** Rozex gel 0.75%

## Key facts

- **NCT ID:** NCT02052999
- **Lead sponsor:** Amorepacific Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-02
- **Primary completion:** 2013-06
- **Final completion:** 2013-08
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2014-02-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02052999

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02052999, "Study to Evaluate the Efficacy and Safety of PAC-14028 Cream in Rosacea Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02052999. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*